FDA Issues Warnings Regarding Hepatitis C Medications Following Drug Injury Reports

by Staff | October 28th, 2015

Federal law requires drug manufacturers to place warning labels on medications explaining the risks the products may pose; however, sometimes problems aren’t discovered until after a medication is released into the market.

For instance, the U.S. Food and Drug Administration (FDA) issued warnings regarding the risks posed by two different medications that are used to treat Hepatitis C. Officials say use of these medications can cause serious liver damage, or even death.

Reports from National Library of Medicine state at least 10 patients have died or have required a liver transplant after using the drugs Viekira Pak or Technivie. Another 16 patients developed a liver dysfunction within weeks of taking their first dose of the drugs.

In response, the FDA is recommending that patients continue taking the medications as prescribed. If a patient experiences fatigue, weakness, loss of appetite, nausea, vomiting, yellowing of the eyes or skin, or light-colored stools, they should speak with their doctor immediately as these could be signs of liver damage.

If you’ve been harmed as a result of taking medication that was prescribed to you, you have the right to seek compensation for your losses through a drug injury lawsuit. Learn more about your rights as a patient by visiting our website. Contact our Terre Haute personal injury attorneys at Fleschner, Stark, Tanoos & Newlin for a free consultation.

Connect With Our Attorneys Now